Compare APPN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APPN | ALVO |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2017 | N/A |
| Metric | APPN | ALVO |
|---|---|---|
| Price | $27.15 | $4.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $33.83 | $9.25 |
| AVG Volume (30 Days) | ★ 1.4M | 498.1K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.59 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $226,743,000.00 | N/A |
| Revenue This Year | $12.18 | $20.85 |
| Revenue Next Year | $11.43 | $44.49 |
| P/E Ratio | $1,316.50 | ★ $18.20 |
| Revenue Growth | ★ 28.29 | N/A |
| 52 Week Low | $21.77 | $3.93 |
| 52 Week High | $46.06 | $11.85 |
| Indicator | APPN | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 51.77 | 30.07 |
| Support Level | $21.77 | N/A |
| Resistance Level | $31.83 | $5.46 |
| Average True Range (ATR) | 1.65 | 0.25 |
| MACD | 0.61 | -0.08 |
| Stochastic Oscillator | 93.08 | 16.00 |
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.